Locations:
Search
Trial may lead to first FDA approval in this realm
Second (or third) time’s a charm in reducing splenomegaly and other symptoms
Study sheds light on value of genetic testing
Using data science to identify intrinsic patterns in cancer data
Advertisement
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services. Policy
Slightly greater risk of bleeding
No evidence of residual tumor or recurrence at 6.5 years of follow-up
Study adds to guidance for urologists
A Q&A with Laura Shoemaker, DO
How one hematologist learned to use and value it
Biological potential of disease better informs AS candidacy
Advertisement
Advertisement